Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section A

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section A

Name:	us-gaap_DeferredRevenueCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Represents the revenue earned during the period pertaining to collaborations, licenses and milestones.

No definition available.

Name:	xncr_CollaborationsLicensesAndMilestonesRevenue
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of additional options associated with the collaborative agreement

No definition available.

Name:	xncr_CollaborativeAgreementNumberOfAdditionalOptionsUnder
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the additional period for which research term may be extended under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementAdditionalResearchTerm
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of nonrefundable upfront fees as provided under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementAnnualMaintenanceFees
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of annual maintenance fees payable during any extension of research term under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementAnnualMaintenanceFeesDuringExtensionOfResearchTerm
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of milestone payment received under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementMilestonePayment
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of milestone payment to be received for first product upon achievement of certain development, regulatory and commercial milestones as per the terms of collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementMilestonePaymentToBeReceivedForFirstProductUponAchievementOfCertainDevelopmentRegulatoryAndCommercialMilestones
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the amount of nonrefundable upfront fees as provided under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNonrefundableUpfrontFees
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of clinical trials initiated, under the collaborative arrangement.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfClinicalTrialsInitiated
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of commercial options provided under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfCommercialOptions
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of compounds.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfCompounds
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of different target programs under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfTargetPrograms
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of technologies to which research license is provided under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfTechnologiesToWhichResearchLicenseProvided
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the amount of option fee that must be paid by counterparty with respect to each target for which the option is exercised as per the terms of the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementOptionFee
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the option term expiring after delivery of the data from a Phase 2 proof-of-concept clinical trial under a collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementOptionTermAfterDeliveryOfDataFromPhase2ProofOfConceptClinicalTrial
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the research license term under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementResearchLicenseTerm
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents information pertaining to the previously indentified programs that can be substitutued during the research term provided Amgen has not initiated non human primate studies

No definition available.

Name:	xncr_NumberOfPreviousIndentifiedProductsInWhichSubstitutionCanOccur
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

Represents informaton in which bispecific technology will be applied to previous targets

No definition available.

Name:	xncr_PreviousTargetsWhichBispecificTechnologyWillBeApplied
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

Period over which revenue is recognized under the agreement

No definition available.

Name:	xncr_RevenueRecognitionContractPeriod
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of consideration that will be recognized upon full completion of milestones set forth in a collaborative agreement between two parties.

No definition available.

Name:	xncr_RevenueRecognitionMilestoneMethodPending
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Name:	us-gaap_CounterpartyNameAxis=xncr_AmgenIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_MorphoSysMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_MerckSharpAndDohmeCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_AlexionPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_JanssenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_CSLLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_NovoNordiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_CollaborationAndLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_CollaborationAndOptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_ResearchAndLicenseAgreement2015Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_Cd38ProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_DiscoveryProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_OptionAndLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_ResearchLicenseAndOptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_ResearchLicenseeAndCollaborationAgreement2007AgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_BoehringerIngelheimInternationalGmbhMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_ResearchLicenseAndCommercialization2009AgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_May2013ResearchLicenseAndCommercializationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_PotentialMilestonesTypeAxis=xncr_DevelopmentBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_PotentialMilestonesTypeAxis=xncr_RegulatoryBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: